ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,085.23
-1.03%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. bluebird bio Inc (BLUE)

  7. bluebird bio Inc (BLUE) News

BLUE bluebird bio Inc

0.9399
0.0274 (3.00%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
bluebird bio Inc BLUE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0274 3.00% 0.9399 09:40:57
Open Price Low Price High Price Close Price Previous Close
0.9102 0.893 0.9458 0.9228 0.9125
more quote information »

Recent News

Date Time Source Heading
27/4/202406:05BWbluebird bio Announces Receipt of Expected Notice from..
26/4/202419:45PRNUSBLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird..
19/4/202419:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
16/4/202419:45PRNUSClass Action Filed Against bluebird bio, Inc. (BLUE) Seeking..
12/4/202419:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
11/4/202422:00BWbluebird bio Reports Inducement Grants Under Nasdaq Listing..
09/4/202419:45PRNUSbluebird bio, Inc. Sued for Securities Law Violations -..
05/4/202420:45PRNUSShareholders that lost money on bluebird bio, Inc.(BLUE)..
26/3/202422:01BWbluebird bio Reports Fourth Quarter and 2023 Annual Results..
26/3/202407:05BWbluebird bio to Host Fourth Quarter and 2023 Annual Results..
18/3/202423:00BWbluebird bio Secures up to $175 Million Debt Financing with..
11/3/202423:00BWbluebird bio Announces First Outcomes-Based Agreement with..
06/3/202409:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202409:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202405:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/1/202400:03EDGAR2Form 8-K - Current report
09/1/202400:00BWbluebird bio Provides Update on Commercial Launch Progress,..
05/1/202400:00EDGAR2Form 8-K - Current report
03/1/202400:00BWbluebird bio to Present at the 42nd Annual J.P. Morgan..
21/12/202309:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/12/202323:42EDGAR2Form 8-K - Current report
20/12/202313:41BWbluebird bio, Inc. Announces Pricing of $125 Million Public..
19/12/202322:10IHMARKETNEWSGoogle $700M Antitrust Settlement, TSMC Chairman Retirement,..
19/12/202309:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202308:48EDGAR2Form 8-K - Current report
19/12/202308:01BWbluebird bio, Inc. Announces Proposed Public Offering of..
14/12/202323:30EDGAR2Form 8-K - Current report
12/12/202300:06EDGAR2Form 8-K - Current report
11/12/202304:02BWLong-Term Data Presented at ASH Support beti-cel as a..
10/12/202303:31BWLong-term Follow-up Data From bluebird’s Gene Therapy..
09/12/202308:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202308:11DJNBluebird Bio Shares Slide 41% on Black-Box Label, Higher..
09/12/202305:01BWbluebird bio Details Plans for the Commercial Launch of..
09/12/202304:35BWbluebird bio Announces FDA Approval of LYFGENIA™..
09/12/202304:03DJNBluebird Bio Gets FDA OK of Lyfgenia Gene Therapy in..
07/11/202323:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:01EDGAR2Form 8-K - Current report
07/11/202323:00BWbluebird bio Reports Third Quarter 2023 Financial Results..
04/11/202307:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202307:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202300:37BWbluebird bio to Present New and Updated Data from Gene..

Your Recent History

NASDAQ
BLUE
bluebird bio
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved